M16-852
ClinicalTrials.gov NCT03725202
Research payments
$582,192
Through program year 2020, $582,192 in research payments was reported against M16-852, across 167 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03725202
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $278,046 | 123 |
| 2019 | Research | $304,147 | 44 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jeffrey Alper Naples, FL Named on 41 payments
- Melvin Churchill Lincoln, NE Named on 16 payments
- Christopher Antolini Denver, CO Named on 11 payments
- William Davis New Orleans, LA Named on 10 payments
- Benidecto Fernandez Hialeah, FL Named on 8 payments
- Robin Dore Tustin, CA Named on 7 payments
- Robert Levin Dunedin, FL Named on 6 payments
- Mona Amin Phoenix, AZ Named on 6 payments
- Bonita Libman Burlington, VT Named on 5 payments
- Alvin Wells Franklin, WI Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.